Paper53657
Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.
Eleftheriou N and 3 others. Lancet, 1975. Cited by 201 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Download JSON
Cite this record
ConductScience Library. Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease. Papers, record 53657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/53657
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies | Major topic |
| Antigens | Major topic |
| Hepatitis B | Major topic |
| Liver Diseases | Major topic |
| Acute Disease | |
| Carrier State | |
| Chronic Disease | |
| Hepatitis | |
| Hepatitis B Antibodies | |
| Hepatitis B Antigens | |
| Humans | |
| Liver Cirrhosis | |
| Liver Neoplasms |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 201 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 15,230,642 | High frequency of the 1896 precore mutation in patients and blood donors with hepatitis B virus infection from the Indian subcontinent. | Mol Diagn | 2004 | https://conductscience.org/library/papers/15230642 | PubMed |
| 11,106,350 | Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. | Clin Chem | 2000 | https://conductscience.org/library/papers/11106350 | PubMed |
| 7,141,198 | Hepatitis B e antigen and antibody in asymptomatic Chinese with hepatitis B surface antigenemia in Taiwan. | Gastroenterol Jpn | 1982 | https://conductscience.org/library/papers/7141198 | PubMed |
| 6,852,624 | Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy. | Gut | 1983 | https://conductscience.org/library/papers/6852624 | PubMed |
| 6,840,863 | The significance of the HBe system in an area highly endemic for hepatitis B virus. | Infection | 1983 | https://conductscience.org/library/papers/6840863 | PubMed |
| 6,790,429 | Recent advances in viral hepatitis: viruses and their serological markers. | Indian J Pediatr | 1980 | https://conductscience.org/library/papers/6790429 | PubMed |
| 6,713,726 | Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6713726 | PubMed |
| 6,368,400 | The significance of the HBeAg/anti-HBe system in hemodialysis patients. A multicenter study. | Infection | 1984 | https://conductscience.org/library/papers/6368400 | PubMed |
| 6,271,968 | Clustering of hepatitis B virus infection and hepatocellular carcinoma in a family. | J R Soc Med | 1981 | https://conductscience.org/library/papers/6271968 | PubMed |
| 4,076,727 | Incidence and significance of hepatitis B and A virus serologic markers in Greek cirrhotic patients. | Gastroenterol Jpn | 1985 | https://conductscience.org/library/papers/4076727 | PubMed |
| 2,312,667 | Effects of recombinant leukocyte interferon on serum immunoglobulin concentrations and lymphocyte subpopulations in chronic hepatitis B. | J Clin Immunol | 1990 | https://conductscience.org/library/papers/2312667 | PubMed |
| 849,558 | Difference in the distribution of e antigen among different ethnic groups in a population of blood donors. | Can Med Assoc J | 1977 | https://conductscience.org/library/papers/849558 | PubMed |
| 781,393 | [The characterization of clinically healthy hepatitis-b-surface-antigen (HBsAg)-carriers. Clinical, biochemical, histiological and immunological investigations in 129 case of a prospective study (author's transl)]. | Klin Wochenschr | 1976 | https://conductscience.org/library/papers/781393 | PubMed |
| 731,022 | e-Antigen: a link between immune response and infectivity in hepatitis B? | J Hyg (Lond) | 1978 | https://conductscience.org/library/papers/731022 | PubMed |
| 702,483 | Clinical aspects of viral hepatitis. | J R Soc Med | 1978 | https://conductscience.org/library/papers/702483 | PubMed |
| 698,557 | HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine. | Br Med J | 1978 | https://conductscience.org/library/papers/698557 | PubMed |
| 648,025 | Immune complexes in acute and chronic liver disease. | Clin Exp Immunol | 1978 | https://conductscience.org/library/papers/648025 | PubMed |
| 608,568 | Clinical significance of e-antigen/anti-e, with special reference to HBc-antigen in the liver. | Gastroenterol Jpn | 1977 | https://conductscience.org/library/papers/608568 | PubMed |
| 599,184 | e Antigen and antibody in outbreaks of hepatitis B in two renal dialysis units. | J Clin Pathol | 1977 | https://conductscience.org/library/papers/599184 | PubMed |
| 591,632 | Occurrence of e antigen in acute hepatitis B. | J Clin Pathol | 1977 | https://conductscience.org/library/papers/591632 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/53657
GET https://conductscience.org/api/papers/v1/53657/cited_by?page=2